process, provide enormous economic advantages to patients and the health care system, with estimates of $338 billion in savings annually from the availability of these medications. Generic drugs ...

and streamlining the process by waiving the requirement that a generic and brand manufacturer share a single system for assuring safe use could be used to eliminate one tool used to slow generics.

Vektor Pharma TF GmbH ("Vektor"), has finalized the formula for its novel transdermal delivery system ("TDS") for the neurologic drug Rotigotine. Vektor is now proceeding with process ...

The FDA said Thursday it will speed up this process by providing better advice to generic manufacturers on how to file a drug application that will be approved on the first try. Currently ...

A proposed rule issued Friday would allow generic-drug makers to update product labeling with new safety information before the FDA reviews and approves the change—a process that brand-name ...

The province will seek competitive bids from companies for exclusive supply contracts for generic prescription drugs, moving from a piecemeal system to a centralized tendering process. It means ...